Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives

Overview of attention for article published in Biomarker Research, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#37 of 357)
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs: 1 blog

twitter: 4 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 59 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 7 X posts from 4 X users, with an upper bound of 6,460 followers.

@MakisMD @stephanie_co239 You have so many drugs used as conjunctive therapies in cancer treatment. There has to be some of these therapies that offer potential treatment for immune modified patients. Atleast hoping so. https://t.co/KCx8UqqMcn

14 Aug 2023

Reply Repost Favourite

@LauraB53831929 Yes! I've heard Stephanie Seneff discuss the role of the toll-like receptors. Your tweet prompted me to do some research: https://t.co/ULej5tUBsR. Thank you, Laura.

01 Jun 2023

Reply Repost Favourite

https://t.co/6X6CJRGhlJ

21 May 2023

Reply Repost Favourite

https://t.co/QZKWRKXy0R

21 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.